von September
files.shareholder.com/downloads/.../Genocea_corporate_deck.pdf
files.shareholder.com/downloads/.../Genocea_corporate_deck.pdf
|
Genocea Reports Third Quarter 2016 Financial Results
Genocea now expects that its existing cash, cash equivalents and marketable securities are sufficient to support its operating expenses and capital expenditure requirements into the first quarter of 2018
Cash Position: Cash, cash equivalents and investments as of September 30, 2016 were $75.5 million compared to $86.0 million as of June 30, 2016.
ir.genocea.com/releasedetail.cfm?ReleaseID=997316
|
Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
120 | Phase II Ergebnisse und News | biotech1x1 | Vassago | 25.04.21 00:22 |